JPRN-jRCT2080220304未知3 期
A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure
ovartis Pharma K.K.0 个研究点目标入组 356 人开始时间: 2006年10月3日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 356
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 65age old 至 ot applicable（—）
入选标准
- •Inclusion criteria
- •- Patients with at least 65 years-old
- •- Patients with essential hypertension
- •Exclusion criteria
- •- Severe hypertension
- •- History or evidence of a secondary form of hypertension
- •- History of Hypertensive encephalopathy or cerebrovascular accident.
- •Other protocol-defined inclusion/exclusion criteria also apply
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Clinical Study on Diabetes supplement in participants with diabetes.CTRI/2024/04/065001Emil Pharmaceutical Industries Private Limited,
尚未招募
2 期
Effect of Boozidaan(Pyrethrum Indicum)on Niqris Muzmin(chronic gout)CTRI/2021/03/032150Central council for Research in Unani Medicine New Delhi
已完成
不适用
Clinical safety and efficacy Study â??ROMANTAQUE LOTIONâ??.CTRI/2015/02/005534Mrs Mrinmayee Bhushan Kondhalkar30
尚未招募
2 期
Clinical study of Softovac Liquifibre in constipatioCTRI/2023/03/051094upin Limited
已完成
2 期
A Clinical study of Ostofix Tablet in subjects suffering from Osteoarthritis of Knee(s)CTRI/2014/02/004373ARJUN HEALTHCARE36